Related Experiment Video
Updated: Jun 24, 2026

Detergent-free Ultrafast Reconstitution of Membrane Proteins into Lipid Bilayers Using Fusogenic Complementary-charged Proteoliposomes.
Published on: April 5, 2018
A two-step continuous flow synthesis of multi-tail ionizable lipids.
Nina Bozinovic1, Graham Atwood2, K Cory MacLeod2
1Center for Continuous Flow Synthesis, FRQNT Centre in Green Chemistry and Catalysis, Department of Chemistry, Université de Montréal, 1375, Ave. Thérèse Lavoie-Roux, Montréal, Québec H2V 0B3, Canada. andre.charette@umontreal.ca.
Continuous flow synthesis offers a safe and efficient method for producing multi-tail ionizable lipids, crucial for RNA therapeutic delivery systems. This process significantly reduces reaction times and enhances safety in lipid manufacturing.
Area of Science:
- Chemical Engineering
- Organic Chemistry
- Materials Science
Background:
- Lipid nanoparticles (LNPs) are essential for delivering RNA therapeutics.
- Current synthesis methods for ionizable lipids can be time-consuming and involve hazardous intermediates.
- Scalable and safe manufacturing processes are needed for LNP components.
Purpose of the Study:
- To develop a robust and safe continuous flow synthesis for multi-tail ionizable lipids.
- To optimize the epoxidation and polyalkylation steps for efficiency and safety.
- To demonstrate the scalability and throughput of the continuous flow process.
Main Methods:
- Continuous flow epoxidation of long-chain terminal alkenes using Oxone/acetone.
- Catalyst-free polyalkylation via high-temperature epoxide ring-opening in flow.
- In-line alkylation of crude epoxidation products.
Main Results:
- Nearly quantitative conversion in epoxidation, safely managing hazardous intermediates.
- Dramatic reduction in reaction time for polyalkylation (20 minutes residence time vs. days in batch).
- Production of representative ionizable lipids with a throughput >10 g/h in a lab setting.
Conclusions:
- Continuous flow synthesis provides a rapid, safe, and scalable method for producing ionizable lipids.
- The developed process overcomes limitations of traditional batch synthesis.
- This approach holds significant potential for industrial-scale manufacturing of LNP components for RNA therapeutics.

